Safety Study of Adoptive Transfer of Autologous IKDC-like Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Neoplasm Metastasis
Interventions
BIOLOGICAL

autologous IKDC-like cells

Subject received autologous IKDC-like cells every 14 days

Trial Locations (1)

114

Tri-Service General Hospital, Taipei

All Listed Sponsors
collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

collaborator

Academia Sinica, Taiwan

OTHER

lead

National Defense Medical Center, Taiwan

OTHER

NCT02661685 - Safety Study of Adoptive Transfer of Autologous IKDC-like Cells | Biotech Hunter | Biotech Hunter